• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Ocera Therapeutics, Inc. (OCRX)

    -NasdaqGM
    5.99 Up 0.34(6.02%) Dec 19, 4:00PM EST
    |After Hours : 5.90 Down 0.09 (1.50%) Dec 19, 7:56PM EST
    Add to Portfolio
    Prev Close:5.65
    Open:5.66
    Bid:5.36 x 100
    Ask:N/A
    1y Target Est:17.00
    Beta:3.75
    Next Earnings Date:N/A
    Day's Range:5.51 - 5.99
    52wk Range:4.47 - 19.94
    Volume:78,626
    Avg Vol (3m):65,213
    Market Cap:118.25M
    P/E (ttm):N/A
    EPS (ttm):-1.58
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    OCRXUp 6.02%118.25M
    IRWDDown 1.79%2.07B
    THRXDown 0.03%1.76B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):307.26
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.56
    Quarterly EPS Est (Dec-14) :-0.45
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Ocera Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the development and commercialization of OCR-002, which is in Phase IIb trials for the treatment of hepatic encephalopathy in patients with liver cirrho... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback